Bionaut Labs
- 05/12/2022
- Series B
- $43,200,000
Bionauts™ are remote-controlled micro-robots revolutionizing the treatment of central nervous system disorders, targeting deep brain structures safely and precisely
- Industry Biotechnology Research
- Website https://bionautlabs.com/
- LinkedIn https://www.linkedin.com/company/bionaut-labs/
Related People
Michael ShpigelmacherCo Founder
I am a Biotech entrepreneur working on a stealth mode startup. Previously, I have spent over 6 years at PDT Partners (formerly Morgan Stanley), as a senior investment researcher creating proprietary investment strategies utilizing AI. Prior to PDT Partners I worked as an engagement manager at McKinsey and Company, where I led a team of consultants focusing on corporate strategy, operations, investment strategy and risk management. I primarily served clients in the healthcare and financial sectors.
Prior to McKinsey I have played a central role in the creation of a Primesense, the company developing the technology behind XBox Kinect and later acquired by Apple. Prior to Primesense, I spent 6 years as a senior product manager for a sophisticated governmental R&D organization. During this period I managed a team of up to 20 experienced engineers and researchers, dealing with complex software and hardware products, a challenging R&D process and close to impossible client requirements.
Specialties: Biotech, robotics, AI, R&D management, capital markets, investment management, risk management, hedging, portfolio optimization, operations, corporate strategy, organizational transformation, project management, product management, strategic planning, mathematical algorithm design, system engineering, financial engineering, software engineering